TMPRSS2 and neoplasm: The ERG−/PTEN+ tumour molecular subtype of PCa is described by the absence of ERG rearrangements, such as TMPRSS2:ERG fusions, and the retention of PTEN function, which is important for controlling the PI3K/AKT signalling pathway (58).